what is glp-1 medications New Guidelines for Type 2 Diabetes in 2025 Chart: 1 in 8 Americans

Retatrutide is an investigational compound developed by Eli Lilly that acts on three hormone receptors: GLP-1, GIP, and glucagon

Another policy change that may help would be to build more extensive nutrition education into the training that medical students and other health care providers receive

Taking Wegovy while breastfeeding is generally not recommended

Option five: document everything

While GLP-1 and GIP primarily regulate insulin secretion and appetite pathways, the addition of glucagon receptor signaling actively allows researchers to study direct increases in cellular energy expenditure, enhanced lipolysis, and accelerated hepatic lipid metabolism